Home › Genetic Signatures Gets CE Mark for 'Superbugs' Kit

Genetic Signatures Gets CE Mark for 'Superbugs' Kit

Apr 20, 2018

NEW YORK (GenomeWeb) – Australian diagnostics manufacturer Genetic Signatures announced today that it has received CE marking for a PCR-based kit to detect extended spectrum beta-lactamase (ESBL) and carbapenemase-producing organisms (CPOs).

The firm's EasyScreen ESBL & CPO Kit detects strains of antibiotic-resistant pathogens, often referred to as "superbugs," in less than three hours with minimal hands-on time. It detects a total of 16 beta-lactam and carbapenem-resistant pathogen targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
15
Featured Webinar

Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

What's Popular?

In Molecular Diagnostics

  1. Thermo Fisher Scientific Gets CE-IVD Mark for NGS Cancer Test

  2. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  3. Abbott Q3 Dx Business Grows 43 Percent

  4. FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug

  5. Roche Diagnostics' Revenues Grow 6 Percent in First Nine Months of 2018

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.